Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
about
Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?HIV-Host Interactions: Implications for Vaccine DesignHumanized hemato-lymphoid system miceRole of HLA Adaptation in HIV EvolutionChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsChimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall StreetEnhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic PeptidesProgress toward curing HIV infection with hematopoietic cell transplantationHIV-1 functional cure: will the dream come true?HIV therapeutic vaccines: moving towards a functional cureStructure and Dynamics of the Native HIV-1 Env TrimerMulti-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersTIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionUsing animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchAn In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene ExpressionChemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of ImmunodominanceDNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent VirusHIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized MiceShort-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections.Recent Insights into the HIV/AIDS Pandemic.Barriers to HIV Cure.Latency reversal and viral clearance to cure HIV-1.A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionSimilarity in viral and host promoters couples viral reactivation with host cell migrationAdvancements in Developing Strategies for Sterilizing and Functional HIV Cures.Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryThe fate and lifespan of human monocyte subsets in steady state and systemic inflammationDouble trouble: HIV latency and CTL escapeProof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo.The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoDisease progression despite protective HLA expression in an HIV-infected transmission pairBroadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV ControllersTargeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like PropertiesTwo-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.A new hypothesis on HIV cure.Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
P2860
Q26765043-E4849AE1-7C89-4568-9470-306ACF4603A6Q26765966-209DB3E4-180E-40E0-B62B-6CE42AD248A7Q26771440-7DEE683B-2B8F-4F4F-8D49-46B972B976ABQ26772713-805CA4BE-63EB-44FD-87E1-E674E2AFA0A9Q26781511-B27B5F9E-060F-483D-8DB8-EA2E0D54FDA4Q26799357-9DBCF706-DC78-462C-9750-B0CF2AB4FF89Q26800123-BD98E1A6-5925-49A2-A649-197B642C348FQ26801269-1FE4E975-FC24-4583-B0D8-D41CA8719412Q26865803-2DA550E2-9E0B-4A2E-A58A-ED4FD8F6ACB7Q27002180-178B0F9B-9F3B-4592-9FF1-588A2DF32C37Q27027570-B9810FAF-1D3B-4D2D-8A6E-1028C9ED2FD4Q27312050-E526CFD6-FCA9-4B3C-8D2F-8813BCC4B28DQ27316403-51A308CD-E33D-4FB8-9CE7-AE95D13A5A98Q28077662-E997FE7F-B9D9-461B-9E5F-F567C5251D4EQ28546918-0B8F71D3-46B4-474F-AB07-D4C30F9FF587Q28552025-42A77591-8EE4-406A-BDAA-16E60C4C5E56Q28554534-83A9C7B7-DA09-428D-AA1C-509FBEC8E5A8Q28607258-AC9A2858-E093-4611-9FD5-24D449DCCFC1Q30234948-EA11A2D1-9CE7-4E22-B575-72A76C2DD1BDQ30235024-931BACAF-6981-42E8-9CB3-F021D8815BEDQ30245414-4CF3EE3D-25D5-4EEE-820F-701980ECA1C6Q30248766-B5ACFEC1-BD7C-4CEF-B11A-1E6816C1F6BAQ30385378-50D6C2FD-7394-4893-97B5-46481FB859E8Q30934059-61076238-5323-4632-8295-02575989D621Q33620546-F997FD83-8108-40E6-89A0-B1AED1C22226Q33640033-B8DB8A8C-A584-4BD6-9B02-3181FE6CCCAAQ33654409-A74F2E66-480D-4FE4-91FD-8041DAFECE99Q33742139-DC1803C8-E0F9-46F4-A1A9-6250EA5831F2Q33886544-BCD2B510-5372-4A0E-B324-E003D4FD0C90Q35222625-A6C53273-A68A-4F98-BCFC-FA0E19C4AD06Q35718251-265F0A67-8A91-44FE-842A-C48F4AACEDF7Q35778783-9416F152-4604-4AF1-A408-4E79C6B520A4Q35804078-AD285F1E-534E-45A5-9139-9DF37E8DD151Q35831895-FDABF82F-D958-4723-A326-5DA8FA47BD35Q35833324-CC87B6E7-517B-4AE3-9483-965CBA4B990AQ35861157-F485F32A-008E-4C6E-B76A-04858F466DC8Q35861190-6E6F8687-5D9C-4502-962D-AB20814A1945Q36028475-CCE2D5DA-878A-4AB7-9BF3-02D7F119B2B6Q36060923-5EB90B43-BA94-4E5E-818D-9F4A7AB6A8F6Q36086345-9EC2E711-E161-4562-B95B-17A126A1BA65
P2860
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@ast
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@en
type
label
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@ast
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@en
prefLabel
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@ast
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@en
P2093
P2860
P50
P356
P1433
P1476
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
@en
P2093
Anthony Rongvaux
Cagan Gurer
David M Valenzuela
Gabriel Ghiaur
George D Yancopoulos
Holly L McHugh
Janet D Siliciano
Leyao Wang
P2860
P2888
P304
P356
10.1038/NATURE14053
P407
P50
P577
2015-01-07T00:00:00Z